Dr. Scott Gottlieb
Special partner, health investment team,
Gottlieb is a special partner on the NEA healthcare investment team. He previously was a venture partner at NEA from 2007-2017 until being appointed to the 23rd Commissioner of the FDA, which he resigned earlier this year. Many of the initiatives Gottlieb started at the FDA are still in place, including efforts to address ongoing drug shortages and approvals of generics. In September, Gottlieb announced joining Aetion’s Board of Directors.